Top

Reactions Weekly

Published in:

01-04-2024 | Exenatide | Case report

Exenatide/liraglutide/semaglutide

Suicidal behaviour and suicidal attempt

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

McIntyre RS, et al. The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion on Drug Safety 23 : 47-55, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1080/14740338.2023.2295397

Title: Exenatide/liraglutide/semaglutide
Suicidal behaviour and suicidal attempt
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Exenatide
Liraglutide
Semaglutide
Diabetes
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56216-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Exenatide/liraglutide/semaglutide

Suicidal behaviour and suicidal attempt

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Methylprednisolone/Valganciclovir

Phentermine

Carboplatin/pemetrexed/osimertinib

Etoposide/Topotecan

Tranexamic-acid

Clomifene